Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Uniti Group jumps amid report TPG, T-Mobile looking at assets (SeekingAlpha) +++ UNITI Aktie +3,18%

BAUSCH HEALTH Aktie

 >BAUSCH HEALTH Aktienkurs 
4.668 EUR    (TradegateBSX)
Ask: 4.708 EUR / 4250 Stück
Bid: 4.627 EUR / 4330 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
BAUSCHHEALTH Aktie über LYNX handeln
>BAUSCH HEALTH Performance
1 Woche: +8,3%
1 Monat: -7,4%
3 Monate: -23,3%
6 Monate: -16,0%
1 Jahr: -20,6%
laufendes Jahr: -23,3%
>BAUSCH HEALTH Aktie
Name:  BAUSCH HEALTH COS.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA0717341071 / A2JQ1X
Symbol/ Ticker:  BVF (Frankfurt) / BHC (NYSE)
Kürzel:  FRA:BVF, ETR:BVF, BVF:GR, NYSE:BHC
Index:  TSXComp
Webseite:  https://www.bauschhealth...
Profil:  Bausch Health Companies Inc. is a diversified healthcare company focused on developing, manufacturing, and marketing branded and generic pharmaceuticals, over-the-counter products, and medical devices. Its portfolio spans gastroenterology, neurology,..
>Volltext..
Marktkapitalisierung:  1615.2 Mio. EUR
Unternehmenswert:  19038.57 Mio. EUR
Umsatz:  9025.91 Mio. EUR
EBITDA:  2978.28 Mio. EUR
Nettogewinn:  133.52 Mio. EUR
Gewinn je Aktie:  0.36 EUR
Schulden:  18192.35 Mio. EUR
Liquide Mittel:  1143.55 Mio. EUR
Operativer Cashflow:  1192.08 Mio. EUR
Bargeldquote:  0.32
Umsatzwachstum:  0.36%
Gewinnwachstum:  -
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  10.11.10 - 0.8578€
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 65.131 USD.
Suchwörter:  BAUSCH HEALTH, BAUSCHHEALTH
Letzte Datenerhebung:  01.04.26
>BAUSCHHEALTH Kennzahlen
Aktien/ Unternehmen:
Aktien: 370.56 Mio. St.
Frei handelbar: 88.27%
Rückkaufquote: -
Mitarbeiter: 20300
Umsatz/Mitarb.: 0.44 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 52.5%
Bewertung:
KGV: 12.5
KGV lG: 1.15
KUV: 0.17
KBV: -
PEG-Ratio: -
EV/EBITDA: 6.39
Rentabilität:
Bruttomarge: 60.88%
Gewinnmarge: 1.48%
Operative Marge: 21.22%
Managementeffizenz:
Gesamtkaprendite: 0.57%
Eigenkaprendite: -
>BAUSCHHEALTH Peer Group
Gesundheit, Augenmedizin, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
31.03.26 - 13:06
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 (PR Newswire)
 
LAVAL, QC, March 31, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter 2026 financial results after market close on Wednesday, April 29, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results......
26.03.26 - 13:03
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program (PR Newswire)
 
Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with applications open through June 2026 LAVAL, QC, March 26, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today......
24.03.26 - 23:15
Is the Options Market Predicting a Spike in Bausch Health Stock? (Zacks)
 
Investors need to pay close attention to BHC stock based on the movements in the options market lately....
17.03.26 - 14:01
Connecticut Office of the Attorney General: If You Bought Certain Generic Prescription Drugs in the United States, You Could Get Money from Current and Future Settlements (PR Newswire)
 
HARTFORD, Conn., March 17, 2026 /PRNewswire/ -- Additional settlements have been reached with some generic prescription drug manufacturers in lawsuits alleging that consumers paid artificially inflated prices for generic prescription drugs. The settling Defendants are Bausch Health US,......
04.03.26 - 01:02
Insiderhandel: EVP, General Counsel verkauft Aktien von Bausch Health Companies im Wert von 39628 USD (Insiderkauf)
 
Carson, Seana - Vorstand - Tag der Transaktion: 2026-03-02...
04.03.26 - 01:02
Insiderhandel: EVP, General Counsel verkauft Aktien von Bausch Health Companies im Wert von 25503 USD (Insiderkauf)
 
Carson, Seana - Vorstand - Tag der Transaktion: 2026-03-03...
28.02.26 - 03:01
Insiderhandel: EVP, General Counsel verkauft Aktien von Bausch Health Companies im Wert von 49909 USD (Insiderkauf)
 
Carson, Seana - Vorstand - Tag der Transaktion: 2026-02-27...
20.02.26 - 18:16
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? (Zacks)
 
IRWD has the edge over BHC with high Linzess demand and upbeat 2026 revenue outlook offsetting pipeline and pricing risks....
19.02.26 - 03:15
Bausch Health (BHC) Q4 Earnings Lag Estimates (Zacks)
 
Bausch (BHC) delivered earnings and revenue surprises of -10.50% and +3.38%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
19.02.26 - 02:18
Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.02.26 - 01:00
Bausch Health (BHC) Q4 2025 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.26 - 23:24
Bausch Health declines on Q4 profit miss (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.26 - 22:54
Bausch Health Companies Posts Q4 Loss (AFX)
 
OTTAWA (dpa-AFX) - Bausch Health Companies Inc. (BHC, BHC.TO) on Wednesday reported a net loss of $112 million for the fourth quarter, compared with a consolidated net income of $93 million for th......
18.02.26 - 22:06
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS (PR Newswire)
 
Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP)1 basis over the prior year period Full-Year Consolidated Revenues of $10.27 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis GAAP Net Loss......
18.02.26 - 22:03
Bausch Health Companies Non-GAAP EPS of $0.32 misses by $0.94, revenue of $1.40B misses by $1.31B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.02.26 - 13:01
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference (PR Newswire)
 
LAVAL, QC, Feb. 17, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Executive Vice President and CFO Jean-Jacques (JJ) Charhon, along with other management team members, will attend the J.P. Morgan Global Leveraged Finance Conference in Miami......
16.02.26 - 22:01
What to Expect From These Drug/Biotech Players This Earnings Season? (Zacks)
 
Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week....
11.02.26 - 17:30
Bausch Health (BHC) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
 
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
11.02.26 - 14:03
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program (PR Newswire)
 
Bausch Health to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC, Feb. 11, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the opening of the 2026 Salix......
04.02.26 - 05:24
Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention (Fool)
 
Bausch Health's turnaround could pay off for value investors patient enough to wait for it....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Es gibt einen Tag, um geboren zu werden, und einen Tag, um zu sterben. - China Weisheit
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!